Biosearch Technologies, the custom primer design arm of LGC, has received approval from the CDC for its Primer and Probe Set and is allowed to be used under FDA-EUA. The 2019-nCoV CDC Probe and Primer Kit for SARS-CoV-2 were tested by the CDC and is now listed under its 'Acceptable Alternative Primer and Probe Sets' for use in the CDC RT-PCR Diagnostic Panel, which runs on Applied BioSystems 7500 Fast Dx Real-Time PCR System with SDS version 1.4 software.
The kits include FAM-BHQ probes and primers; N1, N2 and RP, mixed into a single assay per signature as required by protocols provided by the CDC. Oligos are delivered dried and shipped at ambient temperature.
Points to note:
- Product in stock ships same or next business day
- One of the most affordable commercial kits available - $0.23 per reaction
- From the inventor and source of Black Hole Quencher™ (BHQ™) technology referenced in US CDC protocols
- Proven track record supporting public health crises with the expertise to rapidly scale-up
Note: This content has been edited by a rapidmicrobiology staff writer for style and content.
